|
| Date |
Type |
Disease |
Title |
|
May 09, 2006 |
Events |
CFIDS |
CFIDS LOBBY DAY 2006
This year's event is extra-special because the CFIDS Association will be introducing members of Congress and their staff to the CFS awareness campaign (launching this June), in addition to talking with lawmakers about funding for research and treatment centers, disability and education issues. |
|
Apr 11, 2006 |
Abstract |
CFIDS |
Abstract: Postulated vasoactive neuropeptide autoimmunity in fatigue-related conditions: A brief review and hypothesis
Disorders such as chronic fatigue syndrome (CFS) and gulf war syndrome (GWS) are characterised by prolonged fatigue and a range of debilitating symptoms of pain, intellectual and emotional impairment, chemical sensitivities and immunological dysfunction. |
|
Apr 06, 2006 |
Abstract |
CFIDS |
Abstract: Efficacy of neurotropin in chronic fatigue syndrome: a case report
Chronic fatigue syndrome (CFS) is a disorder that causes general fatigue and chronic widespread pain. A 28-year-old male visited an outpatient department due to general fatigue and pain involving the entire body. He did not suffer from fibromyalgia, but he was diagnosed with CFS. |
|
Mar 27, 2006 |
Abstract |
CFIDS |
Abstract: Submaximal aerobic exercise with mechanical vibrations improves the functional status of patients with chronic fatigue syndrome
Typically, CFS patients complain of a severe fatigue made worse by exercise, with a consistent reduction of working activity. A physical deconditioning could explain CFS features as well as a neuromuscular dysfunction, of central or peripheric origin. |
|
Mar 15, 2006 |
Article |
CFIDS |
Calling for Patients: An Open Label Study of Ampligen in Chronic Fatigue Syndrome
A new open label study of Ampligen for CFS patients is currently recruiting patients (at patients' own expense). Principal investigators include Daniel Peterson, M.D., Lucinda Bateman, M.D., and Charles W. Lapp, M.D. |
|
Mar 01, 2006 |
Abstract |
CFIDS |
Abstract: How relevant are exercise capacity measures for evaluating treatment effects in chronic fatigue syndrome? Results from a prospective, multidisciplinary outcome study
OBJECTIVE: To evaluate the outcome of a multidisciplinary treatment programme for patients with chronic fatigue syndrome, including health-related quality of life (HRQoL) and psychosocial variables, and exercise capacity measures. |
|
Feb 23, 2006 |
Article |
CFIDS |
Chronic Fatigue Syndrome: Complete Text of Revised Case Definition
Information from the Centers for Disease Control and Prevention (CDC). |
|
Feb 15, 2006 |
Abstract |
CFIDS |
Abstract: Chronic Fatigue Syndrome in Cardiology Neurohumoral Changes
Chronic fatique markedly worsens quality of life of cardiological patients. Chronic fatigue and chronic fatigue syndrome are neuro-immuno-endocrine disorders which manifest as moderate and severe even inivalidizing fatigue with psychosomatic symptoms. |
|
Feb 08, 2006 |
Article |
CFIDS |
Chronic Fatigue Syndrome: Is Recovery a Realistic Goal?
Bruce Campbell writes, "When I had cancer, my recovery depended on the stage of the illness and the skill of the doctors. But with CFS, my choices and habits were important. My attitudes and actions affected my symptoms. But affecting symptoms is not the same as creating recovery." |
|
Feb 06, 2006 |
Abstract |
CFIDS |
Abstract: Does methylphenidate reduce the symptoms of chronic fatigue syndrome?
The objectives of this study were to investigate the short-term effects of methylphenidate, an amphetamine derivative, on fatigue, concentration disturbances, and quality of life. |
|
|
Next 10 Articles>> |
|
|
|
